Search For
11 result(s) for 'Pancreatic cancer'
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Open Access Review 30 Jan 2024
DOI: 10.20517/cdr.2023.84
Views: Downloads:
Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
Open Access Commentary 29 May 2023
Views: Downloads:
Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance
Open Access Commentary 9 May 2023
DOI: 10.20517/cdr.2023.06
Views: Downloads:
Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq
Open Access Original Article 17 Oct 2022
DOI: 10.20517/cdr.2022.60
Views: Downloads:
Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
Open Access Review 2 Apr 2022
Views: Downloads:
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance
Open Access Original Article 7 Oct 2021
DOI: 10.20517/cdr.2021.61
Views: Downloads:
Overcoming acquired chemo-resistance to gemcitabine: implications from the perspective of multi-modal therapy including surgery for pancreatic cancer
Open Access Commentary 6 Sep 2021
DOI: 10.20517/cdr.2021.75
Views: Downloads:
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
Open Access Review 13 Apr 2021
DOI: 10.20517/cdr.2021.01
Views: Downloads:
Views: Downloads:
The dark side of immunotherapy: pancreatic cancer
Open Access Review 10 May 2020
DOI: 10.20517/cdr.2020.13
Views: Downloads:
Antibody drug conjugate development in gastrointestinal cancers: hopes and hurdles from clinical trials
Open Access Review 18 Dec 2018
DOI: 10.20517/cdr.2018.16
Views: Downloads:
- 1